1. Home
  2. IGC vs BODI Comparison

IGC vs BODI Comparison

Compare IGC & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • BODI
  • Stock Information
  • Founded
  • IGC 2005
  • BODI 1998
  • Country
  • IGC United States
  • BODI United States
  • Employees
  • IGC N/A
  • BODI N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • IGC Health Care
  • BODI Industrials
  • Exchange
  • IGC Nasdaq
  • BODI Nasdaq
  • Market Cap
  • IGC 33.5M
  • BODI 31.6M
  • IPO Year
  • IGC N/A
  • BODI N/A
  • Fundamental
  • Price
  • IGC $0.37
  • BODI $5.22
  • Analyst Decision
  • IGC Strong Buy
  • BODI Buy
  • Analyst Count
  • IGC 2
  • BODI 2
  • Target Price
  • IGC $3.88
  • BODI $10.00
  • AVG Volume (30 Days)
  • IGC 862.4K
  • BODI 28.2K
  • Earning Date
  • IGC 08-14-2025
  • BODI 08-05-2025
  • Dividend Yield
  • IGC N/A
  • BODI N/A
  • EPS Growth
  • IGC N/A
  • BODI N/A
  • EPS
  • IGC N/A
  • BODI N/A
  • Revenue
  • IGC $1,327,000.00
  • BODI $324,871,000.00
  • Revenue This Year
  • IGC $15.26
  • BODI N/A
  • Revenue Next Year
  • IGC $3.41
  • BODI N/A
  • P/E Ratio
  • IGC N/A
  • BODI N/A
  • Revenue Growth
  • IGC 24.95
  • BODI N/A
  • 52 Week Low
  • IGC $0.25
  • BODI $3.38
  • 52 Week High
  • IGC $0.48
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • IGC 57.43
  • BODI 67.12
  • Support Level
  • IGC $0.35
  • BODI $4.10
  • Resistance Level
  • IGC $0.37
  • BODI $5.12
  • Average True Range (ATR)
  • IGC 0.02
  • BODI 0.41
  • MACD
  • IGC -0.00
  • BODI 0.08
  • Stochastic Oscillator
  • IGC 79.80
  • BODI 73.37

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: